This is fine, but it is yet another molecular test. What we need now are serology tests. They are faster, cheaper, easier to execute (blood-based), can detect cured patients, and can scale to the population of a country.

Serology tests are already used in several countries in Asia, I have little doubt they will arrive in Europe and the US soon-ish.